Exponent sees Q3 revenue before reimbursements up mid-single digits

For the third quarter of 2025, as compared to the same period one year prior, Exponent (EXPO) anticipates: Revenues before reimbursements to be up in the mid-single digits; and, EBITDA1 to be 26.75% to 27.75% of revenues before reimbursements.